Sonnet BioTherapeutics Holdings, Inc. earnings per share and revenue

SONN earnings per share for the last quarter are 0.07 USD whereas the estimation was -0.70 USD which accounts for 110.00% surprise. Företagets omsättning för samma period uppgår till 0.00 USD trots den uppskattade siffran 12.33 k USD. Estimated earnings per share for the next quarter are -0.77 USD, and revenue is expected to reach 28.50 k USD. Also watch annual changes over time to get a bigger picture of SONN earnings per share and revenue dynamics.